Increased PD-1 on CD4+CD28- T cell and soluble PD-1 ligand-1 in patients with T2DM: Association with atherosclerotic macrovascular diseases

Metabolism: Clinical and Experimental

Volumn 62, Issue 6, 2013, Pages 778-785

  Shi, Bimin ^a,c   Du, Xuan ^a   Wang, Qin ^b   Chen, Yongjing ^b   Zhang, Xueguang ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

CD4+CD28 T cell; Macrovascular; PD 1; sPD L1; T2DM

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CD28 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; PROGRAMMED DEATH 1 LIGAND 1;

ACUTE CORONARY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; COCULTURE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD274; ANTIGENS, CD28; ANTIGENS, CD4; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; UP-REGULATION;

EID: 84878017106     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.12.005     Document Type: Article

References (29)

1. J. Ge, Q. Jia, C. Liang, Y. Luo, D. Huang, and A. Sun Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells Arterioscler Thromb Vasc Biol 25 2005 2157 2163
2. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
3. C. Weber, A. Zernecke, and P. Libby The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models Nat Rev Immunol 10 2008 802 815
4. S. Winer, Y. Chan, G. Paltser, D. Truong, H. Tsui, and J. Bahrami Normalization of obesity-associated insulin resistance through immunotherapy Nat Med 15 2009 921 929
5. H. Dong, S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, and D.B. Flies Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 2002 793 800
6. Y. Iwai, M. Ishida, Y. Tanaka, T. Okazaki, T. Honjo, and N. Minato Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Proc Natl Acad Sci USA 99 2002 12293 12297
7. J. Yantha, H. Tsui, S. Winer, A. Song, P. Wu, and G. Paltser Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia Diabetes 59 2010 2588 2596
8. M.L. del Rio, L. Buhler, C. Gibbons, J. Tian, and J.I. Rodriguez-Barbosa PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation Transpl Int 21 2008 1015 1028
9. C.L. Day, D.E. Kaufmann, P. Kiepiela, J.A. Brown, E.S. Moodley, and S. Reddy PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression Nature 443 2006 350 354
10. H. Dong, G. Zhu, K. Tamada, and L. Chen B7-H1. A third member of the B7 family costimulates T cell proliferation and interleukin-10 secretion Nat Med 5 1999 1365 1369
11. S.Y. Tseng, M. Otsuji, K. Gorski, X. Huang, J.E. Slansky, and S.I. Pai B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells J Exp Med 193 2001 839 846
12. T. Honjo, A.H. Sharpe, and G.J. Freeman PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat Immunol 2 2001 261 268
13. C.C. Bleul, and T. Boehm Laser capture microdissection-based expression profiling identifies PD1 ligand as a target of the nude locus gene product Eur J Immunol 31 2001 2497 2503
14. J.F. Viallard, A. Solanilla, B. Gauthier, C. Contin, J. Déchanet, and C. Grosset Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis Blood 99 2002 2612 2614
15. H.W. Jung, S.W. Choi, J.I. Choi, and B.S. Kwon Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis Exp Mol Med 36 2004 13 22
16. Q. Wang, Y. Chen, F. Xie, Y. Ge, L. Chen, and H. Wu Development of a sandwich ELISA assay for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease Cytokine 36 2006 23 28
17. J.A. de Lemos, A. Zirlik, U. Schönbeck, N. Varo, S.A. Murphy, and A. Khera Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study Arterioscler Thromb Vasc Biol 25 2005 2192 2196
18. U. Schönbeck, N. Varo, P. Libby, J. Buring, and P.M. Ridker Soluble CD40L and cardiovascular risk in women Circulation 104 2001 2266 2268
19. Y. Chen, Q. Wang, B. Shi, P. Xu, Z. Hu, and L. Bai Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1 + cell lines Cytokine 56 2011 231 238
20. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity J Clin Invest 97 1996 2027 2037
21. - costimulation- independent T cells in multiple sclerosis J Clin Invest 108 2001 1185 1194
22. G. Liuzzo, S.L. Kopecky, R.L. Frye, W.M. O'Fallon, A. Maseri, and J.J. Goronzy Perturbation of the T-cell repertoire in patients with unstable angina Circulation 100 1999 2135 2139
23. G. Liuzzo, J.J. Goronzy, H. Yang, S.L. Kopecky, D.R. Holmes, and R.L. Frye Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes Circulation 101 2000 2883 2888
24. K. Walsh, R.C. Smith, and H.S. Kim Vascular cell apoptosis in remodeling, restenosis, and plaque rupture Circ Res 87 2000 184 188
25. null T lymphocytes and recurrence of acute coronary events J Am Coll Cardiol 50 2007 1459 1461
26. A. Cantón, E.M. Martinez-Cáceres, C. Hernández, C. Espejo, J. García-Arumí, and R. Simó CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis Arch Ophthalmol 122 2004 743 749
27. G. Buttice, J. Miller, L. Wang, and B.D. Smith Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells Circ Res 98 2006 472 479
28. D.B. Savage, K.F. Petersen, and G.I. Shulman Mechanisms of insulin resistance in humans and possible links with inflammation Hypertension 45 2005 828 833
29. G. Wachlin, P. Augstein, D. Schröder, B. Kuttler, I. Klöting, and P. Heinke IL-6 beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction. J Autoimmunity 20 2003 303 312